Latest Mergers And Acquisitions News

Page 169 of 1112
Albright Metals has completed a key diamond drilling program at its Golden Pike Project in Canada and initiated antimony drilling at Bond Road, supported by a successful $1.98 million capital raise.
Maxwell Dee
Maxwell Dee
23 Jan 2026
North Stawell Minerals has reported encouraging diamond drilling results at its Darlington Project in Victoria, revealing continued high-grade gold mineralisation at depth with strong parallels to the historic Mariners Lode.
Maxwell Dee
Maxwell Dee
23 Jan 2026
EPX Limited has successfully raised nearly $295,000 through a Security Purchase Plan, supporting its recent acquisition of Wattwatchers and positioning the company for further expansion.
Sophie Babbage
Sophie Babbage
23 Jan 2026
Auravelle Metals has reported significant high-grade gold intersections at its Sheoak Prospect in South Australia, extending the gold trend beyond 600 metres and identifying new targets at Sheoak East. Meanwhile, early drilling at its Crown Gold Project in Western Australia confirms extensive gold anomalism, supported by a successful $2.5 million capital raise to fund ongoing exploration.
Maxwell Dee
Maxwell Dee
23 Jan 2026
Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.
Ada Torres
Ada Torres
23 Jan 2026
Strickland Metals has announced a maiden inferred resource of 1.2 million ounces of gold at its Gradina Deposit, lifting the total Rogozna Project resources by 16% to 8.6 million ounces gold equivalent. The company plans an ambitious 60,000-metre drilling campaign in 2026 to further expand and define its Serbian gold-base metals assets.
Maxwell Dee
Maxwell Dee
23 Jan 2026
Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.
Ada Torres
Ada Torres
23 Jan 2026
Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.
Ada Torres
Ada Torres
23 Jan 2026
American Tungsten & Antimony Ltd is progressing its Nasdaq listing plans with a confidential SEC filing expected in March 2026 and has appointed Deutsche Bank as ADR depositary alongside a new CFO to support growth.
Maxwell Dee
Maxwell Dee
23 Jan 2026
Korvest Ltd reported a strong first half for FY2026 with revenue up 17.9% and profit before tax rising 33.2%, driven by growth in its Industrial Products segment and major infrastructure projects.
Victor Sage
Victor Sage
23 Jan 2026
Clover Corporation has initiated an on-market acquisition of up to 3.26 million shares to satisfy future employee share plan vesting, aiming to reduce shareholder dilution from new share issuances.
Victor Sage
Victor Sage
23 Jan 2026
Venus Metals Corporation progresses its Sandstone Bellchambers gold project with a new mining lease and exploration targets, while extending its Bridgetown JV farm-in and navigating an unsolicited takeover offer.
Maxwell Dee
Maxwell Dee
23 Jan 2026